An Act to Require Lyme Disease Vaccine Coverage for State-regulated Health Plans
Impact
The implementation of LD1220 is designed to modify existing health insurance regulations in the state by adding Lyme disease vaccine coverage to the list of required benefits. Consequently, this could significantly impact insurance providers, as they would be compelled to adjust their policies to comply with the new mandate. The bill's effective date is set for January 1, 2024, which means insurers will have to adapt their plans accordingly to meet these new standards.
Summary
LD1220 seeks to mandate that state-regulated health plans provide coverage for Lyme disease vaccines licensed by the FDA. Specifically, the bill stipulates that health insurers must cover any vaccines recommended by healthcare providers without imposing any cost-sharing requirements such as deductibles, copayments, or prior authorizations. This requirement is aimed at improving access to preventative care and ensuring that enrollees receive necessary vaccinations against Lyme disease.
Sentiment
The sentiment surrounding LD1220 appears to be largely positive among health advocates and individuals concerned with Lyme disease, especially given the increasing incidence of this illness. Proponents argue that this legislation will enhance public health and reduce the financial burden on individuals seeking necessary vaccinations. However, some insurance companies might express concern about the potential increase in costs associated with mandatory vaccine coverage.
Contention
While there is general support for the intentions of LD1220, notable points of contention may arise between insurance providers and proponents of the bill. Insurance companies might argue that mandatory coverage for these vaccines could raise operational costs, leading to higher premiums. On the other hand, advocates for public health may counter that the long-term benefits of preventing Lyme disease outbreaks outweigh the potential financial drawbacks for insurers.
Providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.
Providing for patient access to diagnostics and treatments for Lyme disease and related tick-borne illnesses; and requiring health care policies to provide certain coverage.
Requires Medicaid provide health benefits coverage, and places certain requirements on insurers and State Health Benefits Program regarding existing mandate on health benefits coverage, for certain over-the-counter contraceptives.